SERGIO WEHINGER

Dr. SERGIO WEHINGER


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
OFOscar Forero-Doria
Oscar Forero-Doria
EPEfrain Polo
Efrain Polo
Adolfo MaricanAdolfo Marican
Adolfo Marican
LGLuis Guzmán
Luis Guzmán
BVBernardo Venegas
Bernardo Venegas
EDEsteban F. Durán-Lara
Esteban F. Durán-Lara

19 November 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
CSC. Sanhueza
C. Sanhueza
SWSERGIO WEHINGER
SERGIO WEHINGER
JBJ. Castillo Bennett
J. Castillo Bennett
Manuel Valenzuela-ValderramaManuel Valenzuela-Valderrama
Manuel Valenzuela-Valderrama
GOG. I. Owen
G. I. Owen
AQAndrew FG Quest
Andrew FG Quest
Survivin, a member of the inhibitor of apoptosis family of proteins (IAPs) that controls cell division, apoptosis, metastasis and angiogenesis, is overexpressed in essentially all human cancers. As a consequence, the gene/protein is considered an attractive target for cancer treatment. Here, we discuss recent findings related to the regulation of survivin expression and its role in angiogenesis, particularly in the context of hypoxia. We propose a novel role for survivin in cancer, whereby expression of the protein in tumor cells promotes VEGF synthesis, secretion and angiogenesis. Mechanistically, we propose the existence of a positive feed-back loop involving PI3-kinase/Akt activation and enhanced β-Catenin-TCF/LEF-dependent VEGF expression followed by secretion. Finally, we elaborate on the possibility that this mechanism operating in cancer cells may contribute to enhanced tumor vascularization by vasculogenic mimicry together with conventional angiogenesis.

1 March 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DADiego Arauna
Diego Arauna
FGFrancisco García
Francisco García
LRLeocadio Rodríguez-Mañas
Leocadio Rodríguez-Mañas
JMJaume Marrugat
Jaume Marrugat
CSClaudia Sáez
Claudia Sáez
Eduardo FuentesEduardo Fuentes
Eduardo Fuentes

10 June 2019 in Cancers
Verified
Journal Article
Open access
PDF file
Manuel Valenzuela-ValderramaManuel Valenzuela-Valderrama
Manuel Valenzuela-Valderrama
PCPaulina Cerda-Opazo
Paulina Cerda-Opazo
Steffen BackertSteffen Backert
Steffen Backert
MCMaria Fernanda Gonzalez Castro
Maria Fernanda Gonzalez Castro
NCNicolás Carrasco-Véliz
Nicolás Carrasco-Véliz
AQAndrew FG Quest
Andrew FG Quest
Chronic Helicobacter pylori infection increases the risk of gastric cancer and induction of hypoxia-induced factor (HIF), which is frequently associated with the development and progression of several types of cancer. We recently showed that H. pylori activation of the PI3K-AKT-mTOR pathway in gastric cells increased HIF-1α expression. Here, we identified the H. pylori virulence factor responsible for HIF-1α induction. A mutant of the H. pylori 84-183 strain was identified with reduced ability to induce HIF-1α. Coomassie blue staining of extracts from these bacteria separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) revealed poor expression of urease subunits that correlated with reduced urease activity. This finding was confirmed in the 26695 strain, where urease mutants were unable to induce HIF-1α expression. Of note, HIF-1α induction was also observed in the presence of the urease inhibitor acetohydroxamic acid at concentrations (of 20 mM) that abrogated urease activity in bacterial culture supernatants, suggesting that enzymatic activity of the urease is not required for HIF-1α induction. Finally, the pre-incubation of the human gastric adenocarcinoma cell line AGS with blocking antibodies against Toll-like receptor-2 (TLR2), but not TLR4, prevented HIF-1α induction. In summary, these results reveal a hitherto unexpected role for the urease protein in HIF-1α induction via TLR2 activation following H. pylori infection of gastric cells.

1 February 2014 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
SWSERGIO WEHINGER
SERGIO WEHINGER
ROR.J. Ortiz
R.J. Ortiz
NDN. Diaz
N. Diaz
JDJ. Diaz
J. Diaz
lorena Lobos-Gonzalezlorena Lobos-Gonzalez
lorena Lobos-Gonzalez
AQAndrew FG Quest
Andrew FG Quest
Caveolin-1 is a member of the caveolin family that has been ascribed a dual role in cancer. In early stages of disease the protein functions predominantly as a tumor suppressor, whereas at later stages, caveolin-1 expression is associated with tumor progression and metastasis. Here, some mechanisms associated with caveolin-1-dependent tumor suppression will be briefly discussed before focusing on the role of this protein and particularly phosphorylation of tyrosine-14 in promoting cell migration, invasion and metastasis. Models are provided summarizing possible explanations for these dramatic changes in function, as well as mechanisms by which this may be achieved.

1 May 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
SWSERGIO WEHINGER
SERGIO WEHINGER
RORina Ortiz
Rina Ortiz
MDMaría Inés Díaz
María Inés Díaz
AAAdam Aguirre
Adam Aguirre
Manuel Valenzuela-ValderramaManuel Valenzuela-Valderrama
Manuel Valenzuela-Valderrama
AQAndrew FG Quest
Andrew FG Quest